ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

OPTN OptiNose Inc

1.91
0.13 (7.30%)
Mar 01 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 471,937
Bid Price 1.89
Ask Price 1.91
News -
Day High 1.91

Low
0.90

52 Week Range

High
2.07

Day Low 1.77
Share Name Share Symbol Market Stock Type
OptiNose Inc OPTN NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.13 7.30% 1.91 18:32:42
Open Price Low Price High Price Close Price Previous Close
1.77 1.77 1.91 1.91 1.78
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
2,310 471,937 US$ 1.85 US$ 872,858 - 0.90 - 2.07
Last Trade Type Quantity Price Currency
18:30:03 5 US$ 1.9001 USD

OptiNose Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
214.52M 112.31M - 76.28M -74.83M -0.67 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

OptiNose News

Date Time Source News Article
2/29/202415:40GlobeNewswire Inc.Optinose Announces Reporting Date for Fourth Quarter 2023..
2/29/202415:07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
2/29/202415:06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
2/29/202415:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
2/29/202415:04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
2/23/202406:08Edgar (US Regulatory)Form 8-K - Current report
2/22/202415:28Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial..
2/14/202419:48Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial..
2/13/202416:16Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial..
2/01/202413:43Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
1/30/202415:05Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial..
1/18/202411:00GlobeNewswire Inc.Optinose Announces the Publication of ReOpen Phase 3..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No OPTN Message Board. Create One! See More Posts on OPTN Message Board See More Message Board Posts

Historical OPTN Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week1.481.911.481.69674,1540.4329.05%
1 Month1.251.911.201.49425,6750.6652.80%
3 Months1.231.911.111.36338,0710.6855.28%
6 Months1.201.910.95531.30321,6710.7159.17%
1 Year1.822.070.901.31386,9300.094.95%
3 Years4.014.300.902.12325,670-2.10-52.37%
5 Years7.4711.660.903.65329,498-5.56-74.43%

OptiNose Description

OptiNose Inc is a US-based specialty pharmaceutical company that focuses on the development and commercialization of products for patients treated by ear, nose, and throat, and allergy specialists. The lead product of the company, XHANCE nasal spray, utilizes a proprietary breath powered exhalation delivery system, to deliver a topically acting and potent anti-inflammatory corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps. The XHANCE is able to deliver medication to the primary site of inflammation high and deep in the nasal passages in regions not adequately reached by intranasal steroids. The pipeline products of the company include XHANCE, OPN-300, OPN-021, and AVP-825.

Your Recent History

Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 | help@advfn.com